NUVBNuvation Bio Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$32M

Net Income

-$34M

EPS (Diluted)

$-0.16

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$121M

Total Liabilities

$3M

Stockholders' Equity

$118M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$32M	-$992,000	-3135.8%
Net Income	-$34M	-$992,000	-3282.3%

NUVB FY 2019 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena